EP0738325A1 - Rezeptor - spezifische bekterielle Adhesine und ihre Verwendung - Google Patents

Rezeptor - spezifische bekterielle Adhesine und ihre Verwendung

Info

Publication number
EP0738325A1
EP0738325A1 EP95906910A EP95906910A EP0738325A1 EP 0738325 A1 EP0738325 A1 EP 0738325A1 EP 95906910 A EP95906910 A EP 95906910A EP 95906910 A EP95906910 A EP 95906910A EP 0738325 A1 EP0738325 A1 EP 0738325A1
Authority
EP
European Patent Office
Prior art keywords
adhesin
fimh
val
gly
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95906910A
Other languages
English (en)
French (fr)
Inventor
Evgeni Veniaminovic Sokurenko
David Long Hasty
Per Klemm
Lars Pallesen
Soren Molin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GX BioSystems AS
University of Tennessee Research Foundation
Original Assignee
GX BioSystems AS
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GX BioSystems AS, University of Tennessee Research Foundation filed Critical GX BioSystems AS
Publication of EP0738325A1 publication Critical patent/EP0738325A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
EP95906910A 1994-01-27 1995-01-27 Rezeptor - spezifische bekterielle Adhesine und ihre Verwendung Withdrawn EP0738325A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18716694A 1994-01-27 1994-01-27
US187166 1994-01-27
PCT/DK1995/000042 WO1995020657A1 (en) 1994-01-27 1995-01-27 Receptor specific bacterial adhesins and their use

Publications (1)

Publication Number Publication Date
EP0738325A1 true EP0738325A1 (de) 1996-10-23

Family

ID=22687857

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95906910A Withdrawn EP0738325A1 (de) 1994-01-27 1995-01-27 Rezeptor - spezifische bekterielle Adhesine und ihre Verwendung

Country Status (4)

Country Link
EP (1) EP0738325A1 (de)
AU (1) AU1532795A (de)
CA (1) CA2180726A1 (de)
WO (1) WO1995020657A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2330699A1 (en) * 1998-04-30 1999-11-11 Gyre Ltd. Multifunctional adhesin proteins and their display in microbial cells
GB9819484D0 (en) * 1998-09-07 1998-10-28 Univ Bristol Therapeutic agents
DE19850718C1 (de) 1998-11-03 2000-05-18 Hildt Eberhardt Zellpermeabilität-vermittelndes Polypeptid
AU6349700A (en) * 1999-07-15 2001-02-05 Med Immune, Inc. Fimh adhesin-based vaccines
WO2002004496A2 (en) * 2000-07-07 2002-01-17 Medimmune, Inc. Fimh adhesin proteins and methods of use
WO2002059156A2 (en) 2000-12-22 2002-08-01 Medimmune, Inc. Therapeutic compounds structurally-linked to bacterial polypeptides
US20040067544A1 (en) * 2002-06-27 2004-04-08 Viola Vogel Use of adhesion molecules as bond stress-enhanced nanoscale binding switches
US9452205B2 (en) 2012-09-24 2016-09-27 Montana State University Recombinant Lactococcus lactis expressing Escherichia coli colonization factor antigen I (CFA/I) fimbriae and their methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000614A1 (en) * 1988-07-13 1990-01-25 Baylor College Of Medicine Receptor specific proteins and their use in receptor typing
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9520657A1 *

Also Published As

Publication number Publication date
WO1995020657A1 (en) 1995-08-03
AU1532795A (en) 1995-08-15
CA2180726A1 (en) 1995-08-03

Similar Documents

Publication Publication Date Title
AU767143B2 (en) Lactobacilli harboring aggregation and mucin binding genes as vaccine delivery vehicles
Kapperud et al. Plasmid-mediated surface fibrillae of Yersinia pseudotuberculosis and Yersinia enterocolitica: relationship to the outer membrane protein YOP1 and possible importance for pathogenesis
Lee et al. Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice
JP4146516B2 (ja) ウェルシュ菌ワクチン
Locht Molecular aspects of Bordetella pertussis pathogenesis
JP4179627B2 (ja) コレラワクチンとしての欠失変異体
Duim et al. Antigenic drift of non‐encapsulated Haemophilus influenzae major outer membrane protein P2 in patients with chronic bronchitis is caused by point mutations
Kelly et al. Characterization and protective properties of attenuated mutants of Salmonella choleraesuis
Guidolin et al. Genetics of Vibrio cholerae and its bacteriophages
CN102630166A (zh) 抗霍乱和肠产毒性大肠杆菌（etec）腹泻的疫苗
Stentebjerg-Olesen et al. Authentic display of a cholera toxin epitope by chimeric type 1 fimbriae: effects of insert position and host background
US4761372A (en) Mutant enterotoxin of E. coli
JP2009173667A (ja) 病原菌のｔｉｒ遺伝子によってコードされる、病原菌の宿主の膜受容体、ｈｐ９０
US5098998A (en) Cholera vaccines and peptides
JP2009022299A (ja) 変異Ｓｈｉｇｅｌｌａｆｌｅｘｎｅｒｉ２ａ
EP0738325A1 (de) Rezeptor - spezifische bekterielle Adhesine und ihre Verwendung
US5330753A (en) Cholera vaccines
AU656730B2 (en) Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof
JP2777894B2 (ja) コレラワクチン
High Haemophilus influenzae
EP0202260A1 (de) Verbesserte antigenzusammensetzung.
US5468639A (en) Isolated DNA molecule encoding ShET2 of Shigella flexneri 2a
Holmgren et al. Vaccine Development for the Control of Cholera and Related Toxin‐Induced Diarrhoeal Diseases
Yakhchali Expression of foreign epitopes in CS3 fimbriae
AU2003236302B2 (en) Virulence genes and proteins, and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960822

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970801